Table 2.

Prevalence of FGID in PWE (N = 120) compared to HS (N = 113).

	PWE	HS	p-value
Total patients with FGID (at least one FGID)	75 (62.5)	45 (39.8)	<0.001
Dyspepsia subtype- post-prandial distress syndrome	13 (10.8)	13 (11.5)	n.s.
Dyspepsia subtype- epigastric pain syndrome	4 (3.3)	7 (6.2)	n.s.
Nausea and vomiting	0 (0.0)	3 (2.7)	n.s.
Belching	2 (1.7)	1 (0.9)	n.s.
Chest pain/heartburn	3 (2.5)	1 (0.9)	n.s.
Dysphagia	4 (3.3)	0 (0.0)	n.s.
Pharyngeal globe	3 (2.5)	0 (0.0)	n.s.
Regurgitation	1 (0.8)	0 (0.0)	n.s.
IBS	16 (13.3)	15 (13.3)	n.s.
IBS with diarrhea	3 (2.5)	4 (3.5)	n.s.
IBS with constipation and diarrhea	3 (2.5)	0 (0.0)	n.s.
Unclassified IBS	1 (0.8)	4 (3.5)	n.s.
IBS with constipation	9 (7.5)	7 (6.2)	n.s.
Functional constipation	43 (35.8)	17 (15)	<0.001
Total amount of patients with constipation	52 (43.3)	24 (21.2)	<0.001
Functional diarrhea	4 (3.3)	2 (1.8)	n.s.
Abdominal bloating	4 (3.3)	0 (0.0)	n.s.

FGID, functional gastrointestinal disorder; HS, healthy subject; IBS, irritable bowel syndrome; PWE, patient with epilepsy.